Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Allogeneic γδ T cells(Peking University Third Hospital) in Glioblastoma Multiforme: NCT07144735 Clinical Landscape Report 2026
9 min read
Allogeneic γδ T cells(Peking University Third Hospital) in Glioblastoma Multiforme: NCT07144735 Clinical Landscape Report 2026
18 September 2026
NCT07144735 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
UBT-251 in Metabolic Dysfunction Associated Steatohepatitis: NCT07145151 Clinical Landscape Report 2026
9 min read
UBT-251 in Metabolic Dysfunction Associated Steatohepatitis: NCT07145151 Clinical Landscape Report 2026
18 September 2026
NCT07145151 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
Read →
Lomustine in Recurrent Glioblastoma: NCT07145112 Clinical Landscape Report 2026
9 min read
Lomustine in Recurrent Glioblastoma: NCT07145112 Clinical Landscape Report 2026
18 September 2026
NCT07145112 clinical landscape for Recurrent Glioblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Amoxicillin Trihydrate in Metabolic Dysfunction Associated Steatohepatitis: NCT07159412 Clinical Landscape Report 2026
9 min read
Amoxicillin Trihydrate in Metabolic Dysfunction Associated Steatohepatitis: NCT07159412 Clinical Landscape Report 2026
18 September 2026
NCT07159412 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
Read →
HSK-42360 in Glioblastoma Harboring BRAF V600 Mutation: NCT07158710 Clinical Landscape Report 2026
9 min read
HSK-42360 in Glioblastoma Harboring BRAF V600 Mutation: NCT07158710 Clinical Landscape Report 2026
18 September 2026
NCT07158710 clinical landscape for Glioblastoma Harboring BRAF V600 Mutation: endpoints, sponsor, phase, geography, readouts, asset context and development w…
Read →
Oncolytic virus(Mianyang Central Hospital) in Recurrent Glioblastoma: NCT07145047 Clinical Landscape Report 2026
9 min read
Oncolytic virus(Mianyang Central Hospital) in Recurrent Glioblastoma: NCT07145047 Clinical Landscape Report 2026
18 September 2026
NCT07145047 clinical landscape for Recurrent Glioblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
SG-001 (SineuGene) in Amyotrophic Lateral Sclerosis: NCT07169175 Clinical Landscape Report 2026
9 min read
SG-001 (SineuGene) in Amyotrophic Lateral Sclerosis: NCT07169175 Clinical Landscape Report 2026
18 September 2026
NCT07169175 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Treprostinil palmitil in Alveolitis, Extrinsic Allergic: NCT07179380 Clinical Landscape Report 2026
9 min read
Treprostinil palmitil in Alveolitis, Extrinsic Allergic: NCT07179380 Clinical Landscape Report 2026
18 September 2026
NCT07179380 clinical landscape for Alveolitis, Extrinsic Allergic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Riluzole in Amyotrophic Lateral Sclerosis: NCT07174492 Clinical Landscape Report 2026
9 min read
Riluzole in Amyotrophic Lateral Sclerosis: NCT07174492 Clinical Landscape Report 2026
18 September 2026
NCT07174492 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
COYA-302 in Amyotrophic Lateral Sclerosis: NCT07161999 Clinical Landscape Report 2026
9 min read
COYA-302 in Amyotrophic Lateral Sclerosis: NCT07161999 Clinical Landscape Report 2026
18 September 2026
NCT07161999 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Perflutren lipid microsphere in Glioblastoma Multiforme: NCT07179328 Clinical Landscape Report 2026
9 min read
Perflutren lipid microsphere in Glioblastoma Multiforme: NCT07179328 Clinical Landscape Report 2026
18 September 2026
NCT07179328 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Atorvastatin Calcium in Metabolic Dysfunction Associated Steatohepatitis: NCT07180745 Clinical Landscape Report 2026
9 min read
Atorvastatin Calcium in Metabolic Dysfunction Associated Steatohepatitis: NCT07180745 Clinical Landscape Report 2026
18 September 2026
NCT07180745 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
Read →